Thymoquinone Around Immediate Implant

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-55
Sponsorshaimaa hamdy

About this trial

use of Thymoquinone hydrogel with bone graft in comparison to bone graft only around immediate implant-this hydrogel fill the jumping zone in comparison to using hydrogel bone graft only to increase primary stability and enhance osseointegration

Eligibility criteria

Qualifiers

1- Patients ages more than 18 years old, Participants were chosen according to specific eligibility criteria, requiring them to be healthy individuals classified as ASA I by the American Society of Anesthesiologists.

Disqualifiers

Pathologies or drugs that alter tissue integration with dental implants. 2- Head and neck radiation therapy. 3- Renal disease, bleeding disorders and anticoagulant therapy. 4- Pregnant females. 5- Patients with severe para-functional habits and unfavorable occlusion 6- Smokers. 7- Malaligned teeth and teeth with acute periapical pathosis.

Trial design

Treatments tested in this trial

  • group 1 xenograft hydrogel
  • immediat implant placement wit TQ and bone graft hydrogel placement around implant

Treatment groups

44 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

shaimaa hamdy

Lead sponsor

Minia University

Sponsor institution